Concepedia

Ravishankar Ramachandran

RR

Statistics

Publications

45

Citations

1.4K

H-Index

21

Active since

1994

Affiliations

Central Drug Research Institute(Current)

Academy of Scientific and Innovative Research

Council of Scientific and Industrial Research

Indian Institute of Toxicology Research

King George's Medical University

Ravishankar Ramachandran is an author at Central Drug Research Institute specializing in life sciences, biochemistry, and molecular biology.

ORCID

Publications per year

1994–2021

45

Publications

45

NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis

Sandeep Kumar Srivastava, Rama P. Tripathi, Ravishankar Ramachandran · Journal of Biological Chemistry · 2005 · 157 citations · Full text

, , +17

Mutational studies on HslU and its docking mode with HslV

Hyun Kyu Song, Claudia Hartmann, Ravishankar Ramachandran et al. · Proceedings of the National Academy of Sciences · 2000 · 138 citations

, , +16

Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia

Mohd Parvez Khan, Abhishek K. Singh, Amit Joharapurkar et al. · Diabetes · 2015 · 72 citations

, , +17

Functional interactions of HslV (ClpQ) with the ATPase HslU (ClpY)

Ravishankar Ramachandran, Claudia Hartmann, Hyun Kyu Song et al. · Proceedings of the National Academy of Sciences · 2002 · 68 citations

, , +16

Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: evidence for estrogen receptor β-mediated osteogenic action of medicarpin

Biju Bhargavan, Divya Singh, Abnish K. Gautam et al. · The Journal of Nutritional Biochemistry · 2011 · 65 citations

, , +17

1–5 of 45